Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Compositions and methods for RNA-based antimicrobial drug targeting

Patent ·
OSTI ID:1576387

A ribonucleic acid (RNA) based modular regulatory element (MRE) for inhibiting translation of a target gene transcript in an organism (e.g. a pathogen) includes a first segment of RNA capable of forming a stem loop structure, a second segment of RNA downstream of the first segment of RNA and having a target sequence capable of binding to the target gene transcript (or polycistron lead gene transcript), and a third segment of RNA downstream of the second segment of RNA and being capable of forming a terminator hairpin downstream of the target sequence. Methods for assaying the role of a putative target gene in an organism include inhibiting expression of various target genes using the RNA-based MRE.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC52-06NA25396
Assignee:
Triad National Security, LLC (Los Alamos, NM)
Patent Number(s):
10,400,240
Application Number:
15/884,265
OSTI ID:
1576387
Country of Publication:
United States
Language:
English

Similar Records

Double-stranded RNA transcribed from vector-based oligodeoxynucleotide acts as transcription factor decoy
Journal Article · 2015 · Biochemical and Biophysical Research Communications · OSTI ID:22458469

RNA polymerase II mediated transcription from the polymerase III promoters in short hairpin RNA expression vector
Journal Article · 2006 · Biochemical and Biophysical Research Communications · OSTI ID:20798742

Widespread Polycistronic Transcripts in Fungi Revealed by Single-Molecule mRNA Sequencing
Journal Article · 2015 · PLoS ONE · OSTI ID:1627758